Publication | Open Access
The additive antianginal action of oral nifedipine in patients receiving propranolol: magnitude and duration of effect.
32
Citations
13
References
1982
Year
HypertensionPlacebo AdministrationPharmacotherapyExperimental PharmacologyStable AnginaAdditive Antianginal ActionBlood PressureThrombosisExerciseOral NifedipineApplied PhysiologyCardiologyHealth SciencesHeart RateAntihypertensive TherapyPharmacologySide EffectCardiovascular DiseaseExercise PhysiologyPhysiologyClinical PharmacologyMedicine
Ten men with stable angina not completely relieved by full doses of propranolol (mean 218 mg/day) were administered an oral dose of 10 mg of nifedipine or placebo on alternate mornings in a double-blind fashion. Patients had been trained in a protocol that precipitated angina after 3-6 minutes of bicycle exercise. On test days, with propranolol continued, bicycle exercise to angina or fatigue was performed before nifedipine or placebo administration, and hourly thereafter for 8 hours. Mean exercise duration was greater 1 hour after nifedipine than after placebo by 123 seconds (372 +/- 21 vs 249 +/- 16 seconds, p less than 0.001). By the fifth hour, the increase in exercise time was reduced to 93 seconds (p less than 0.001), and a significant, though further diminished, difference of 57 seconds was still present at 8 hours (p less than 0.01). Nifedipine lowered resting systolic blood pressure by 20 mm Hg (p less than 0.001) without appreciably changing heart rate. We conclude that nifedipine is a very effective and reasonably long-acting antianginal supplement to propranolol.
| Year | Citations | |
|---|---|---|
Page 1
Page 1